BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15552923)

  • 1. [Allogeneic hematopoietic stem cell transplantation of myelodysplastic syndrome with pulmonary tuberculosis].
    Yamashita K; Nomiyama J; Takahashi T; Ando T; Tsuru M; Matsubara A; Sato Y; Hatao K; Murakami K; Tanizawa Y
    Nihon Naika Gakkai Zasshi; 2004 Oct; 93(10):2207-9. PubMed ID: 15552923
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation.
    Kook MH; Yhim HY; Lee NR; Song EK; Kim HS; Yim CY; Kwak JY
    Korean J Intern Med; 2014 Jan; 29(1):123-5. PubMed ID: 24574844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allogeneic hematopoietic stem cell transplantation for MDS secondary to Shwachman-Diamond syndrome: a case report].
    Zhou M; Jiang YW; Chen JJ; Wu C; Zou BB; Chen Z; Li L; Lei P; Liu GH; Tian YY; Zhu ML; Liu C
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):80. PubMed ID: 36987731
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.
    Simonetta F; Guerne PA; Tirefort Y; Masouridi-Levrat S; Roosnek E; Chalandon Y
    Joint Bone Spine; 2015 May; 82(3):216-7. PubMed ID: 25547608
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.
    Mukherjee S
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation in a patient with myelodysplastic syndrome and polyarteritis nodosa: a case report and systematic review.
    Stavenga M; Leavis HL; de Witte TM; Raymakers RA
    Ann Hematol; 2016 Mar; 95(4):645-7. PubMed ID: 26787416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Granulocyte transfusion for the treatment of prolonged pneumonia in a patient with MDS-RAEB-2 at allogeneic hematopoietic stem cell transplantation].
    Morita R; Hashino S; Takahashi S; Kanamori H; Onozawa M; Kahata K; Kondo T; Imamura M; Asaka M
    Rinsho Ketsueki; 2008 Feb; 49(2):89-93. PubMed ID: 18341038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.
    Ocheni S; Oyekunle A; Kröger N; Ayuk F; Klyuchnikov E; Arps S; Held K; Zabelina T; Adjallé R; Wolschke C; Zander AR; Bacher U
    Acta Haematol; 2011; 125(3):175-8. PubMed ID: 21196720
    [No Abstract]   [Full Text] [Related]  

  • 9. Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation.
    Fujisaki G; Kami M; Murashige N; Kishi Y; Inokuchi C; Tanosaki R; Momomura S
    Bone Marrow Transplant; 2005 Jan; 35(2):211-2. PubMed ID: 15531900
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?".
    Maziarz RT; Mesa RA; Tefferi A
    Mayo Clin Proc; 2003 Aug; 78(8):941-3. PubMed ID: 12911040
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.
    Shah NN; Bacher U; Fry T; Calvo KR; Stetler-Stevenson M; Arthur DC; Kurlander R; Baird K; Wise B; Giralt S; Bishop M; Hardy NM; Wayne AS
    Am J Hematol; 2012 Sep; 87(9):916-22. PubMed ID: 22473867
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT).
    Ho AY; Mijovic A; Pagliuca A; Mufti GJ
    Bone Marrow Transplant; 1997 Dec; 20(11):1007-8. PubMed ID: 9422485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia.
    Cutler C
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):77-81. PubMed ID: 25696838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of universal vitiligo after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.
    Zhai Y; Wang Q; Li Y; Liu L; Zhou H; Fu C; Miao M; Wu D; Jin S
    Ann Hematol; 2023 Jan; 102(1):209-210. PubMed ID: 36376597
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients.
    Hiramoto N; Kurosawa S; Tajima K; Okinaka K; Tada K; Kobayashi Y; Shinohara A; Inoue Y; Ueda R; Tanaka T; Kim SW; Yamashita T; Heike Y; Fukuda T
    Eur J Haematol; 2014 Feb; 92(2):137-46. PubMed ID: 24127668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azacitidine in the treatment of pediatric therapy-related myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
    Inoue A; Kawakami C; Takitani K; Tamai H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e322-4. PubMed ID: 24608072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It?
    Oran B
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S43-9. PubMed ID: 26297277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome.
    Cutler C
    Hematology Am Soc Hematol Educ Program; 2010; 2010():325-9. PubMed ID: 21239814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.